Biochemistry professor Ernesto Abel-Santos and former postdoc Amber Howerton were recently issued a patent (#9,079,935) that describes a novel compound designed to prevent Clostridium difficile (C. diff) infections. Read more about his research in the related pieces below:

Abel-Santos Discusses Clostridium difficile »
Abel-Santos Team Receives $3.25 Million Grant from NIH »
Battling Bacteria »